一份针对ADMA Biologics Inc (ADMA Biologics) 的做空报告,其核心论点似乎建立在推测性论断之上,而这些论断的来源既不明朗,也缺乏可靠性支撑。
一份针对ADMA Biologics Inc (ADMA Biologics) 的做空报告,其核心论点似乎建立在推测性论断之上,而这些论断的来源既不明朗,也缺乏可靠性支撑。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.